Status: Recruiting
The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
Observational cohort randomized controlled study to study the influence of correction of ID by intravenous injection of ferric carboxymaltose (Ferinject®) on quality of life indicators, functional status in a cohort of patients with HFpEF.
Participants needed: 100
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Tomsk National Research Medical Center of the Russian Academy of SciencesUpdated: Jun 24, 2026Locations: 1
Eligibility criteria
Signed informed consent to participate in the study; [+4]
Uncontrolled arterial hypertension; [+12]